PlainRecalls
FDA Drug Low Class III Terminated

Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30

Reported: February 15, 2017 Initiated: October 13, 2016 #D-0468-2017

Product Description

Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30

Reason for Recall

Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.

Details

Units Affected
5,904 bottles
Distribution
US Nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 5,904 bottles.
Why was this product recalled?
Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 15, 2017. Severity: Low. Recall number: D-0468-2017.